🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

"Fortunately, AI can help bring underrepresented patient populations into clinical trials through 'virtual patients,'" Dr. Jo Varshney explains in this PM360 article. "Virtual patients are computer-generated models that mimic the physiological and biological diversity seen

“Historically, drug developers face limited incentives to address the needs of patients with lower economic potential, as including them in trials often incurs costs that don’t align with anticipated returns. But if we can reduce or eliminate these costs, we could shift this

"More than 95% of diseases either lack drugs or do not have drugs that truly work. If you do the math, there are simply not enough drugs reaching the market. The costs are rising, and innovation is suffering with the current fundraising market. There is less investment in

With BIOiSIM, "(VeriSIM Life) identified a molecule and now in less than two years, we’re putting together a whole IND package for the drug,” Dr. Jo Varshney explains in this Citeline article. Read more about alternatives to animal testing and how BIOiSIM is one premier

The use of Artificial Intelligence (AI) is becoming increasingly prevalent in drug discovery and development and holds the potential to address the challenges in ADC development. AI requires substantial amounts of high-quality data to make reliable predictions of a novel ADC’s

Attending the JPM Healthcare Conference next week? Schedule a meeting with our team to learn more about how partnering with VeriSIM Life can help get your next breakthrough drug to market faster. Book some time with our team: bit.ly/3Bs6zXT

Next week, Dr. Jo Varshney will be one of the leaders selected to participate in the San Francisco Business Times Bizwomen #MentoringMonday event! Learn more: bizjournals.com/sanfrancisco/e…

“The use of AI has already gained tremendous momentum in drug discovery and clinical trial optimization. But we’re on the precipice of a new phase of innovation in biology-first approaches that simulate complete organ systems, metabolic reactions, and patient diversity,” Dr.

Dr. Varshney is honored to be selected as a Finalist for the 'Executive Leader Award - Woman Executive of the Year' in the Women in AI Awards North America 2025! This was a great honor, spanning across 250 nominations in 12 award categories. Stay tuned for details on the winners

“The pharmaceutical industry needs drastic change, and Dr. Varshney is all in on making that happen. As Founder and CEO, VeriSIM Life, Jo leads a team of world-class scientists, machine learning engineers, and in silico simulation experts bringing clarity to drug development

Dr. Jo Varshney is honored to be leading the panel "Advancements in AI for Health Care" at the San Francisco Business Times event, "Intersect 2025: AI-Health Care Symposium" in April. The AI-Health Care Intersect Symposium, hosted by the San Francisco Business Times, Silicon Valley

“By combining data with detailed biological knowledge, our platform reduces development risks, uncovers new opportunities, and enables faster, more confident go/no-go decisions. This drives efficiency, lowers costs, and accelerates the development of more effective therapies,

In this Pharma Manufacturing article, Dr. Jo Varshney emphasizes that in 2025, AI and machine learning will become integral to proactive safety management in pharmacovigilance, transforming the pharmaceutical industry's engagement with real-world data and patient safety. Read

The conversation around AI in drug development is louder than ever—but are we truly seeing a revolution, or are we still navigating through the hype? Check out these insights from Dr. Varshney in Pharma's Almanac: bit.ly/4iLqpxS

🚀 "At VeriSIM Life, we’re harnessing AI-powered digital twins to transform clinical trials—making them safer, smarter, and more efficient. As global healthcare faces uncertainty, we're staying strategic and focused on innovation that drives results." - Our founder & CEO, Dr. Jo

Congrats to Jo Varshney (CEO Jo Varshney) and her VeriSIM Life team on this award. #NewMedsMatter Global Health & Pharma ghpnews.digital/winners/verisi…